Pharmacometric characterization of dabigatran hemodialysis - sprookjes - yvandenbroek - TriplyDB

Pharmacometric characterization of dabigatran hemodialysis

Pharmacometric characterization of dabigatran hemodialysis

http://www.wikidata.org/entity/Q29584461

about

Reversing the anticoagulation effects of dabigatran.Management of gastrointestinal bleeding in patients anticoagulated with dabigatran compared with warfarin: a retrospective, comparative case review.Enhanced elimination of dabigatran through extracorporeal methods.Selecting antithrombotic therapy for patients with atrial fibrillation.Monitoring the Effects and Antidotes of the Non-vitamin K Oral Anticoagulants.Dabigatran anticoagulation and Stanford type A aortic dissection: lethal coincidence: Case report with literature review.What is the role of renal replacement therapy in the setting of dabigatran toxicity?Considerations for Systemic Anticoagulation in ESRD.Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review.Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model Pharmacokinetic assessment in patients receiving continuous RRT: perspectives from the Kidney Health Initiative.[Management of hemorrhage in patients treated with direct oral anticoagulants].

P2860

Q30400249-011A6698-422F-42B2-B352-C6D7CE980AE7 Q33803111-AC62C5EA-7DC2-48AC-9C4A-38266BAD1C61 Q35210137-CDC2396C-C358-4C63-B027-F5195866D36A Q35650380-48276B07-46A9-4566-9E9D-414B2D0935F3 Q36458797-98692DB3-1385-4EAB-826F-8FF03F3BA526 Q38193882-C8B2D2E6-8652-44C4-B9C3-42B2FD07DD2A Q38195315-6B666A0F-3956-47F1-8BE9-CA6A8E3DE623 Q38464975-E0E8D478-AAA3-4E13-B183-B107167F596F Q38566089-5F7BA463-6A49-4A29-9895-CF78CCF33909 Q40765852-C78F2143-D332-4F6F-AC27-35C17CAF4D0D Q41819424-6FD8B474-B0D5-4752-B156-307940FF9C7A Q52665628-6B1C1DF2-EC35-4470-A870-772ACFBA3706

P2860

Pharmacometric characterization of dabigatran hemodialysis

http://www.wikidata.org/entity/Q29584461

description

2013 nî lūn-bûn

@nan

2013 scientific article

@en

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

name

Pharmacometric characterization of dabigatran hemodialysis

@ast

Pharmacometric characterization of dabigatran hemodialysis

@en

type

label

Pharmacometric characterization of dabigatran hemodialysis

@ast

Pharmacometric characterization of dabigatran hemodialysis

@en

prefLabel

Pharmacometric characterization of dabigatran hemodialysis

@ast

Pharmacometric characterization of dabigatran hemodialysis

@en

P1433

Q29584461-C1757E0E-089D-4729-B0AF-5B62F2FAE5F6

P1476

Q29584461-53305D33-3A7D-4CB8-8D74-AE7E6B8C6A02

P2093

Q29584461-298533CE-968B-42A8-83F6-F3B481AA7EA2

Q29584461-55A9F9B8-5571-44D8-9346-A4609F0E2BF7

Q29584461-61BAE53E-6F75-4FD1-837A-39EACA02A20B

Q29584461-69373C61-3267-4755-B999-B25B22995DAA

Q29584461-92418408-1709-4F81-8E2E-99F9FD5ED2DF

Q29584461-A1CB60F1-9EE0-453C-94D7-8F70C484E373

P2283

Q29584461-3a381bc6-4f4a-3055-66ce-98acadf4c0c8

Q29584461-bce8c89f-4f96-304a-b8d1-e21c523b8d86

Q29584461-edb5fff2-465f-5f61-3f85-4f30dc96bc8a

P2860

Q29584461-080E9D48-59C6-48F3-B162-50B0F1284EF4

Q29584461-1087DB98-93E3-4A89-AA76-0B9352EBFD8F

Q29584461-24E21B36-4633-4AE2-BD2B-4C76E6F508D6

Q29584461-3A62AC38-6F24-4D85-9F78-B75AFC41AC59

Q29584461-3C87E3CE-EB49-4B74-A37E-5F9A551E779F

Q29584461-6F8D9B97-2B18-4D29-B900-0EFC07EDB3D9

Q29584461-7926EB09-98E4-40A9-923C-46652550A11F

Q29584461-9332B455-90FE-4034-9078-B4C50F83FFE8

Q29584461-978B971D-ED1D-4430-A15B-965E3B3D32BE

Q29584461-A6770B33-B93A-4D32-ADC1-A8099C3001B4

P2888

Q29584461-193BB8BA-A23A-4B4F-8C27-2734CE1DEC21

P304

Q29584461-631BDCCE-E9D1-4673-A4B0-B7A223652D4F

P31

Q29584461-43A0A80D-678F-4C70-801B-1C4B2D755AF7

P356

Q29584461-F0230134-9599-47C7-BA52-2C171C2A372C

P407

Q29584461-BC0DC973-7854-4D20-86CA-F12907DE6E0D

P433

Q29584461-E491EFCC-F377-483C-AA11-7B6731A877E9

P478

Q29584461-DE90739A-EC3F-4D1D-88E7-EF4C145B56D8

P577

Q29584461-BB39E58C-C940-4599-8AE8-1D1DA60A8FF2

P5875

Q29584461-C0C788B8-A631-4045-AD81-D44EEDB84CFD

P6179

Q29584461-839CEF03-D79F-4C43-A910-FC6DC04BA418

P698

Q29584461-B07E1BF7-23B3-4644-8D08-579060888154

P932

Q29584461-097F3790-5CE0-4B09-9F2B-711FE6677CAF

P356

S40262-013-0049-6

P1433

Clinical Pharmacokinetics

P1476

Pharmacometric characterization of dabigatran hemodialysis

@en

P2093

Alexander Staab

http://www.w3.org/2001/XMLSchema#string

Andreas Clemens

http://www.w3.org/2001/XMLSchema#string

Karl-Heinz Liesenfeld

http://www.w3.org/2001/XMLSchema#string

Sebastian Härtter

http://www.w3.org/2001/XMLSchema#string

Stephan Formella

http://www.w3.org/2001/XMLSchema#string

Thorsten Lehr

http://www.w3.org/2001/XMLSchema#string

P2283

Berkeley Madonna

P2860

Dabigatran versus warfarin in patients with atrial fibrillation

Increasing dialysate flow rate increases dialyzer urea mass transfer-area coefficients during clinical use.

Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects.

Quantitation of dialysis: historical perspective.

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects.

Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study.

Safe use of hemodialysis for dabigatran removal before cardiac surgery.

Twice daily dosing of dabigatran for stroke prevention in atrial fibrillation: a pharmacokinetic justification.

Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, with coadministration of digoxin.

The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans.

P2888

s40262-013-0049-6

P304

453-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40262-013-0049-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236081510

http://www.w3.org/2001/XMLSchema#string

P6179

1048655711

http://www.w3.org/2001/XMLSchema#string

P698

23529813

http://www.w3.org/2001/XMLSchema#string

P932

3663980

http://www.w3.org/2001/XMLSchema#string